What are the challenges/drawbacks in real-world use of Cangrelor (i.v. P2Y12i) ?

What are the practical challenges in use of novel intravenous P2Y12 receptor inhibitor 'Cangrelor' in adjunct to PCI? What are the advantages and disadvantages as compared to other anti-platelets?

18 January 2022 4,848 0 View